CME HOURS/ACCREDITATION

This activity is being sponsored by Boston University School of Medicine.

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Course participation includes reading and listening to online presentations, taking part in online group discussions, reading and responding to in-depth case studies, applying knowledge and practice to patients, and completing a final self-evaluation.

The following chart indicates the maximum available CME credits per course:

*Physicians should only claim credit commensurate with the extent of their participation in the activity.

Physicians can earn additional AMA PRA Category 1 Credit(s)™ in the following ways:

**Participate in a “card study”: With the guidance of the course director, participants will identify 4-6 patients meeting the criteria for intervention discussed in each educational module; specific patient information will be collected on the cards; cards will be stored within the participant’s office; at three months post-intervention, updated patient information will be reviewed, de-identified, and reported.

Boston University School of Medicine designates this educational activity for a maximum of 5 AMA PRA Category 1 Credit(s)™.

***Create a Performance Improvement component to augment any module: This component will require chart reviews of 10 randomly selected patients; the development and implementation of an action plan; and a follow-up chart review after three months.

Boston University School of Medicine designates this educational activity for a maximum of 20 AMA PRA Category 1 Credit(s)™.

Each of the above augmentations requires an additional time commitments. Contact the Boston University CME office (617) 638-4605 or www.bu.edu/cme for more information and to enroll.

Term of Approval

Date of Release: September, 2007
Expiration Date: September, 2010

Course Director

John M. Wiecha, MD, MPH
Associate Professor
Director, Distance Education for Health
Director of Predoctoral Education
Department of Family Medicine
Boston University School of Medicine

Faculty Member has nothing to disclose with regards to commercial interests.

Course Faculty

Advance Directives Module:
Laura N. Goldman, MD
Assistant Professor
Department of Family Medicine
Boston University School of Medicine

Faculty Member has nothing to disclose with regard to commercial interests.

Depression Module:
Larry Culpepper, MD
Chair, Department of Family Medicine

Faculty Member is a consultant for Forest Labs, Pfizer, Wyeth, Neurocrine, and Lilly; and is on the speakers' bureaus of Forest Labs, Pfizer, and Wyeth.

Diabetes Module:
Elliot Sternthal, MD
Division of Endocrinology
Boston Medical Center

Faculty Member is on the speakers’ bureaus of Eli Lilly, Amylin, Merck, Astra Zeneca, GlaxoSmithKline, Takeda, and Novartis.

Colorectal Cancer Screening Module:
Milagros C. Rosal, Ph.D.
Associate Professor of Medicine
Division of Preventive and Behavioral Medicine
Department of Medicine
University of Massachusetts Medical School

Faculty Member has nothing to disclose with regard to commercial interests.

Heart Failure Module:
Jeremy Golding, MD
Clinical Associate Professor
Family Medicine and Community Health
UMass Medical School

Faculty member is a stockholder of the Stryker Foundation.

Medical Errors Module:
Charles Williams, MD
Clinical Instructor
Department of Family Medicine
Boston University School of Medicine

Preventive Cardiology Module:

Frank Domino, MD
Associate Professor and Clerkship Director, University of Massachusetts Medical School
Attending Physician, UMass-Memorial Health Care

Faculty member is a stockholder in RxPalm, Inc., and a Consultant for Wolters Kluwer, Inc. Faculty member does not plan on discussing unlabeled/investigational uses of a commercial product.

Shannon Jenkins, MD
Assistant Professor
Department of Political Science
University of Massachusetts

Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussion unlabeled/investigational uses of a commercial product.

Stacey Potts, MD
Residency Director
University of Massachusetts Medical School Worcester Family Medicine Residency

Faculty member has nothing to disclose with regard to commercial support. Faculty member does not plan on discussion unlabeled/investigational uses of a commercial product.

Disclosure Policy

Boston University School of Medicine asks all individuals involved in the development and presentation of Continuing Medical Education (CME) activities to disclose all relationships with commercial interests. This information is disclosed to CME activity participants. Boston University School of Medicine has procedures to resolve apparent conflicts of interest. In addition, faculty members are asked to disclose when any discussion of unapproved use of pharmaceuticals and devices occurs.

All faculty disclosure information will be posted on this website (www.bu.ehttp://www.bu.edu/fammed/cmetips).

Target Audience

Primary care physicians.

Educational Needs Addressed

Physicians in solo and small-group practices, due to financial constraints and relentless patient care demands, experience barriers to accessing professional development programs essential for maintaining high standards of clinical care and patient safety. A high-quality, internet-based, interactive CME program may address some of the educational inadequacies, and meet the needs of solo and small-group practice clinicians in providing improved practice performance and patient care.

Specific issues to be addressed can be categorized under three broad headings: patient safety as affected by office systems, patient safety as a result of appropriate and timely cancer screenings, and quality of care of patients with chronic illnesses.

READ MORE

Program Learning Objectives

At the conclusion of the seven modules of this program, participants will be able to:

1. Reduce risk of medical error and malpractice associated with cancer screening, diagnosis, follow-up, and counseling.
2. Learn how to directly apply the most recent relevant clinical trial evidence to patients with common chronic illness.
3. Improve quality of care of patients with chronic illnesses, including cardiac disease, diabetes, and depression.
4. Implement feasible and flexible practice improvement activities.

Disclaimer

THESE MATERIALS AND ALL OTHER MATERIALS PROVIDED IN CONJUNCTION WITH CONTINUING MEDICAL EDUCATION ACTIVITIES ARE INTENDED SOLELY FOR PURPOSES OF SUPPLEMENTING CONTINUING MEDICAL EDUCATION PROGRAMS FOR QUALIFIED HEALTH CARE PROFESSIONALS. ANYONE USING THE MATERIALS ASSUMES FULL RESPONSIBILITY AND ALL RISK FOR THEIR APPROPRIATE USE. NEITHER TRUSTEES OF BOSTON UNIVERSITY NOR THE DEVELOPERS OF THE MATERIALS MAKE ANY WARRANTIES OR REPRESENTATIONS WHATSOEVER REGARDING THE ACCURACY, COMPLETENESS, CURRENTNESS, NONINFRINGEMENT, MERCHANTABILITY, OR FITNESS FOR A PARTICULAR PURPOSE OF THE MATERIALS. IN NO EVENT WILL THE TRUSTEES OF BOSTON UNIVERSITY OR THE DEVELOPERS OF THESE MATERIALS BE LIABLE TO ANYONE FOR ANY DECISION MADE OR ACTION TAKEN IN RELIANCE ON THE MATERIALS. IN NO EVENT SHOULD THE INFORMATION IN THE MATERIALS BE USED AS A SUBSTITUTE FOR PROFESSIONAL CARE.

Funding

This project was made possible through a grant from the Physicians' Foundation for Health Systems Excellence and is supported in part by unrestricted educational grants from Pfizer, GlaxoSmithKline, The Olympus Medical Charitable Foundation, and Beckman Coulter.